What is CytoAgents worth?
$52.0Mlast known valuation
CytoAgents last raised $7.0M in its Early Stage VC (May 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for CytoAgents
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2023 | Early Stage VC | $7.0M | ▮ | ▮ |
| Jul 2021 | Early Stage VC | $6.1M | ▮ | ▮ |
How CytoAgents's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CytoAgents, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is CytoAgents worth?
- CytoAgents's last known valuation is $52.0M.
- How much has CytoAgents raised?
- CytoAgents has raised $38.6M in total funding across 2 recorded rounds.
- When did CytoAgents last raise?
- CytoAgents last raised in May 2023 (Early Stage VC), raising $7.0M.